Synthetic luteinizing hormone releasing hormone (LHRH) vaccine for effective androgen deprivation and its application to prostate cancer immunotherapy (Q41463585)

From Wikidata

Jump to navigation Jump to search

scientific article published on March 2004

Language	Label	Description	Also known as
English	Synthetic luteinizing hormone releasing hormone (LHRH) vaccine for effective androgen deprivation and its application to prostate cancer immunotherapy	scientific article published on March 2004

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

1 October 2017

Synthetic luteinizing hormone releasing hormone (LHRH) vaccine for effective androgen deprivation and its application to prostate cancer immunotherapy (English)

1 reference

Europe PubMed Central

PubMed publication ID

1 October 2017

1 reference

based on heuristic

inferred from title

author name string

Connie L Finstad

1

1 reference

Europe PubMed Central

PubMed publication ID

1 October 2017

Chang Yi Wang

2

1 reference

Europe PubMed Central

PubMed publication ID

1 October 2017

Jacek Kowalski

3

1 reference

Europe PubMed Central

PubMed publication ID

1 October 2017

Meilun Zhang

4

1 reference

Europe PubMed Central

PubMed publication ID

1 October 2017

Ming Lie Li

5

1 reference

Europe PubMed Central

PubMed publication ID

1 October 2017

Xuan Mao Li

6

1 reference

Europe PubMed Central

PubMed publication ID

1 October 2017

Wei Guo Xia

7

1 reference

Europe PubMed Central

PubMed publication ID

1 October 2017

Maarten C Bosland

8

1 reference

Europe PubMed Central

PubMed publication ID

1 October 2017

Krishna K Murthy

9

1 reference

Europe PubMed Central

PubMed publication ID

1 October 2017

Alan M Walfield

10

1 reference

Europe PubMed Central

PubMed publication ID

1 October 2017

Wayne C Koff

11

1 reference

Europe PubMed Central

PubMed publication ID

1 October 2017

Timothy J Zamb

12

1 reference

Europe PubMed Central

PubMed publication ID

1 October 2017

language of work or name

0 references

publication date

1 March 2004

1 reference

Europe PubMed Central

PubMed publication ID

1 October 2017

1 reference

Europe PubMed Central

PubMed publication ID

1 October 2017

22

1 reference

Europe PubMed Central

PubMed publication ID

1 October 2017

9-10

1 reference

Europe PubMed Central

PubMed publication ID

1 October 2017

1300-1313

1 reference

Europe PubMed Central

PubMed publication ID

1 October 2017

Treatment of prostate cancer with gonadotropin-releasing hormone agonists

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2003.08.044

7 January 2021

Vaccines for control of fertility and hormone-dependent cancers

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2003.08.044

7 January 2021

Carcinoma of the prostate

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2003.08.044

7 January 2021

Leuprolide versus diethylstilbestrol for metastatic prostate cancer

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2003.08.044

7 January 2021

Anti-GnRH antibodies can induce castrate levels of testosterone in patients with advanced prostate cancer

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2003.08.044

7 January 2021

Ability of an anti-luteinizing hormone-releasing hormone vaccine to inhibit gonadotropins in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2003.08.044

7 January 2021

Monoclonal antibodies against LHRH: development and immunoactivity in vivo and in vitro.

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2003.08.044

7 January 2021

Development of an antifertility vaccine for pets based on active immunization against luteinizing hormone-releasing hormone

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2003.08.044

7 January 2021

Active immunization against LHRH alone or combined with LHRH-analogue treatment impedes growth of androgen-dependent prostatic carcinoma

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2003.08.044

7 January 2021

Highly immunogenic and fully synthetic peptide-carrier constructs targetting GnRH

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2003.08.044

7 January 2021

Use of Prior Vaccinations for the Development of New Vaccines

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2003.08.044

7 January 2021

Effective synthetic peptide vaccine for foot-and-mouth disease in swine

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2003.08.044

7 January 2021

Synthetic AIDS vaccine by targeting HIV receptor

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2003.08.044

7 January 2021

Synthetic IgE peptide vaccine for immunotherapy of allergy

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2003.08.044

7 January 2021

Solid Phase Peptide Synthesis. I. The Synthesis of a Tetrapeptide

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2003.08.044

7 January 2021

Solid phase synthesis

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2003.08.044

7 January 2021

DDA as an immunological adjuvant

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2003.08.044

7 January 2021

Establishment and characterization of seven Dunning rat prostatic cancer cell lines and their use in developing methods for predicting metastatic abilities of prostatic cancers.

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2003.08.044

7 January 2021

Immune responses in mice following immunization with chimeric synthetic peptides representing B and T cell epitopes of measles virus proteins

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2003.08.044

7 January 2021

The invasin protein of Yersinia spp. provides co-stimulatory activity to human T cells through interaction with beta 1 integrins

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2003.08.044

7 January 2021

Receptors for luteinizing hormone-releasing hormone (LHRH) in Dunning R3327 prostate cancers and rat anterior pituitaries after treatment with a sustained delivery system of LHRH antagonist SB-75.

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2003.08.044

7 January 2021

Effect of active immunization against luteinizing hormone-releasing hormone on the androgen-sensitive Dunning R3327-PAP and androgen-independent Dunning R3327-AT2.1 prostate cancer sublines

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2003.08.044

7 January 2021

Anti-gonadotropin releasing hormone vaccines and their potential use in the treatment of hormone-responsive cancers

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2003.08.044

7 January 2021

Workgroup 4: spontaneous prostate carcinoma in dogs and nonhuman primates

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2003.08.044

7 January 2021

New GnRH-like peptide construct to optimize efficient immunocastration of male pigs by immunoneutralization of GnRH.

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2003.08.044

7 January 2021

Vaccination of boars with a GnRH vaccine (Improvac) eliminates boar taint and increases growth performance

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2003.08.044

7 January 2021

Depot gonadotropin-releasing hormone agonist blunts the androgen-induced suppression of spermatogenesis in a clinical trial of male contraception

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2003.08.044

7 January 2021

Long-term GnRH-agonist administration revealed a GnRHindependent mechanism stimulating FSH discharge in humans

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2003.08.044

7 January 2021

Overview consensus statement. Newer approaches to androgen deprivation therapy in prostate cancer

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2003.08.044

7 January 2021

Changes of hormonal function of the adrenal and gonadal glands in baboons of different age groups

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2003.08.044

7 January 2021

Direct inhibitory actions of GnRH on accessory reproductive organs of rat.

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2003.08.044

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2003.08.044

1 reference

Europe PubMed Central

PubMed publication ID

1 October 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 October 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41463585&oldid=2098047569"